IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?

Authors
Citation
Jp. Seery, IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?, ARTHRITIS R, 2(6), 2000, pp. 437-440
Citations number
29
Categorie Soggetti
Rheumatology
Journal title
ARTHRITIS RESEARCH
ISSN journal
14659913 → ACNP
Volume
2
Issue
6
Year of publication
2000
Pages
437 - 440
Database
ISI
SICI code
1465-9913(2000)2:6<437:ITMCTT>2.0.ZU;2-B
Abstract
Transgenic mice overexpressing IFN-gamma in the epidermis develop an inflam matory skin disease resembling cutaneous lupus erythematosus shortly after birth. By 3 months of age, most female transgenics develop a lupus-like syn drome characterised by production of IgG anti-dsDNA, antihistone and antinu cleosome autoantibodies. The autoantibodies are nephritogenic, with one-thi rd of females developing a severe immune complex mediated glomerulonephriti s. Analysis of these transgenics suggests that pathogenic autoantibodies ar ise via an antigen-driven T-cell-dependent mechanism with apoptotic keratin ocytes acting as a potential source of autoantigen. The mechanism of autoan tibody production in IFN-gamma transgenics may be relevant to human lupus a nd is consistent with a central role for cutaneous T cells in the pathogene sis of systemic lupus erythematosus in man.